Australia's largest stock trading and investment forum Australia's #1 stock forum

MEM memphasys limited.

20.0%

0.4¢

MEM Discussion, page-33

First 33 Last

Share
Profile

Follow
Quest09

1,846 Posts.

176

17/04/25

10:54

Post #: 78726608
Share
Originally posted by Quest09: ↑

Do you really think you are delivering medicine.?

All you are doing is exposing yourself as ignorant of the facts and ignorant of reality.....essentially just emotional.

As i said....you invest in a micro-cap that is transitioning from product development to product commercialisation and you become emotional at the prospect of a capital boost requirement. You and your Illogically pessimistic attitude have been exposed.
Those with a more stoic and clear vision of reality may come to the conclusion that MEM is a growth company which has just successfully completed a pivotal clinical trial in which results reflected a "best in class" performance of its flagship product.........and hance MEM is on the precipice of commercialisation.

MEM also have various initial commercial partnerships in place.....and has stated that commercial negotiations are ongoing with these commercial partners (some of these partners are multi-billion dollar companies).

IMO, in terms of positioning, i would suggest that MEM is very well positioned and has a very positive future.

Expand

Originally posted by Melbstock: ↑

It's all white noise when it's coming from you champ. But i really hope some of the wilder points in your ramps come to fruition.

For what it's worth, I'm not a pharmacist.

Expand

Buddy, its not coming from ME...... it is coming from ASX market sensitive announcements....

I am just reading the facts within the context of reality and the broader picture (as opposed to having an emotional response to a short term capital requirement).

Now that you are backtracking on your emotional attack on me.......it would be a good time for you to apologise. I will accept "sorry, i was wrong to emotionally attack your facts based posts" or just a simple, "sorry" will do.

Originally posted by Quest09: ↑

Looking forward to an update on the Heranova China study and potential commercial roll-out agreement. As per the below, there seems to be sooo much potential in this deal in particular.

"MEM is pleased to announce the commencement of in vitro utilisation testing of its Felix™ System in China, as part of the agreement with Heranova Lifesciences HK Limited........."

"Subject to positive results, Memphasys and Heranova will work towards an exclusive distribution agreement with the option of licensing and manufacturing the Felix TM System in the Territory, and finance of clinical trials and applications for NMPA Registration in the China."
"Results to pave the way to access China’s IVF market, valued at USD 5.37 billion in 2023, is projected to grow to USD 9.04 billion by 2030."

Expand

Originally posted by Quest09: ↑

China is facing a significant population decline issue.

The population has been shrinking for several years, with the fertility rate falling well below the replacement level of 2.1 births per woman. This decline is attributed to factors like the legacy of the one-child policy, rising living costs, and changing societal attitudes among younger generations.
The Chinese government has introduced various measures to address this challenge. These include:
Policy Changes: The one-child policy was relaxed to allow two children in 2016 and three children in 2021.
Financial Incentives: Subsidies for childbirth, housing support, and increased borrowing limits for families with multiple children.
Childcare Support: Establishing childcare service centers and expanding maternity insurance to include flexible and rural workers.
Healthcare Improvements: Covering labor pain relief and assisted reproductive technologies under medical insurance.

With headlines like the below, it seems that a MEM deal could progress very quickly in the Chineses market:

Expand

Originally posted by Quest09: ↑

The Heranova trial in China is the most exciting aspect of MEM's current and future prospects IMO.

China is the one of the biggest markets globally for IVF, if not the biggest, and as per the above attached posts, China has active government policies which are promoting child birth within the declining population of China.

IMO, all things seem well aligned for MEM and Heranova to provide Felix as commercial solution to China's declining population problem. Interestingly, China is also globally known as a factory production powerhouse....and can produce products at a relatively cheap cost by global standards......so any commercial agreement between MEM and Heranova could also easily include the production of the Felix System in China at a relatively inexpensive cost of production (so many factories in China looking for new customers).

The Heranova study aims to test 50 patients in China and has been ongoing now for about 3 months. I can't imagine it would take long to complete a trial of 50 patients in China, considering they have such a large population (1.4 billion people).

IMO, an update on the Heranova agreement could be just around the corner......and could be potentially transformative for MEM as a company.

Expand

Originally posted by Quest09: ↑

Another interesting prospect which we could receive an update on at any time is the Brazilian market entry via Lab Androscience.

Clinical trial was due to run for about three months...which is now near completion....and additionally Lab Androscience will also now have the MEM clinical trial results to review, which is of course a much bigger trial.

From the announcement in February:
"sophisticated investors associated with Laboratorio Androscience have expressed an interest in supporting Memphasys’ activities in the country............... they are likely to invest to facilitate market entry via a licensing arrangement...........the Company (MEM) will keep the market fully informed should a proposal be received that warrants disclosure."

Expand

Originally posted by Quest09: ↑

A snapshot of how MEM's Felix System compares to the conventional methods of IVF sperm separation.

As MEM states "best in class" with "clear advantages in performance, quality and operating costs."

Expand

Originally posted by Quest09: ↑

Rough timeline provided by MEM for how the Heranova deal in China may playout.

Results of the China clinical trial and initial special access commercial sales could start as early as April 2025 (which is NOW).

Options for local manufacturing in China of the Felix Device in around October 2025.

Expand

Originally posted by Quest09: ↑

A merger and acquisition (M&A) is a real likelihood at these prices IMO.

A $10 to $12 million dollar market cap for MEM is tiny compared to the IP we have on the Felix device (a technology which has been proven to be "best in class"). The market which is available to MEM via that IP and via the IVF industry is huge.

As per below slide, M&As are relatively common in this space.....and with such a small market cap....MEM could see itself as a target.

Expand

Originally posted by Quest09: ↑

Cooper Surgical and Vitrolife are competitors in the healthcare equipment space , particularly in fertility and reproductive health technologies. Cooper Surgical, a subsidiary of Cooper Companies, develops products for medically assisted reproduction. Vitrolife operates in a similar field, making it one of Cooper Surgical’s top rivals.

My understanding is that Cooper Surgical has a market cap of approx US $15 billion dollars......and Vitrolife has a market cap of approx US $2.7 billion dollars.

Vitrolife currently has a distribution agreement with MEM on the Felix device.....and Cooper Surgical might want to eliminate that competition.

Imagine of Cooper Surgical decided to undermine its competitor (Vitrolife), by putting up an offer to buy MEM at its currently low market cap.

That would be quite the trump card for Cooper, essentially shutting its competitor (Vitrolife) out of the picture on an IVF technology considered to be "best in class".

It would really be something if Vitrolife come back with a counter offer......essentially starting a bidding war for the Felix device and or a M&A.

As per the above attached post.....merger and acquisition deals are quite common in this space.

Expand

Originally posted by Quest09: ↑

Are you still emotional over a capital raise which was clearly on the horizon, clearly inevitable, and clearly required to progress the commercialisation of the Felix system.?

So much more going on which is relevant to the bigger picture and some people cant help but have an emotional response to an obvious short term company requirement.

At a current market cap of approx $12 million dollars, MEM is significantly undervalued IMO.

Expand

Originally posted by Quest09: ↑

It is bizarre that some Hotcopper users buy into a micro-cap growth company which is transitioning from product development to product commercialisation, and then become surprised and emotional at the prospect of a capital boost requirement.......

SO BIZZARRE.

MEM is on track and on target IMO.

The future looks bright IMO.

Expand
MEM Price at posting: 0.6¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CKF

Profits after tax down -88%, and shares rocket – what's going on with Collins?

MPK

Many Peaks accelerating gold hunt in Côte d'Ivoire after assay 'justification'

SPN

Sparc opens small-scale green H2 plant in SA, but liquidity dried up

BRK

Bullish Brookside expands with fifth DSU at 'highly sought after' American oil and gas field

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

First 33 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change -0.001(20.0%)		Mkt cap ! $7.934M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$500	125K

Buyers (Bids)

No.	Vol.	Price($)
18	6446273	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	4914915	11

View Market Depth

No.	Vol.	Price($)
18	6446273	0.004
7	3423249	0.003
4	3644000	0.002
5	7850000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	4914915	11
0.006	5904481	11
0.007	9744169	9
0.008	2884385	8
0.009	1180000	2

Last trade - 10.29am 24/06/2025 (20 minute delay)

MEM (ASX) Chart